Exogenous TFEB localization in astrocytes has been shown to enhance lysosomal function and reduce Aβ levels and amyloid plaque load in the hippocampus of amyloid precursor protein/presenilin-1 (APP/PS1) transgenic mice, a murine model of AD. Here, APP is linked to Alzheimer disease.